Feeds

Drug trial guinea pig faces new medical battle

Diagnosed with cancer

Security for virtualized datacentres

One of the victims of the disastrous drug trial at Northwick Park Hospital earlier this year says he has now been diagnosed with the early stages of cancer.

The disease is attacking New Zealander David Oakley's lymphatic system, part of the immune system. He told The BBC: "It's an early sign of cancer. The best I could actually get was that if we catch it early enough it is treatable."

Six men who were hospitalised by TGN1412, an experimental treatment designed to combat immune conditions such as arthritis and multiple sclerosis, along with certain forms of leukaemia.

But instead of damping down the immune system, the compound over-stimulated it, causing the massive swelling which prompted one woman to describe her boyfriend as looking like "The Elephant Man".

After the tests went badly wrong, the men were warned they could face developing cancer, though there is no proof the trial caused Mr Oakley's condition.

An inquiry by the Medicines and Healthcare products Regulatory Authority found the trial operator Parexel had not liased properly with the drug's German developers TeGenero.

The volunteers' lawyers are currently seeking greater compensation than the initial £5,000 they were offered in April. ®

Security for virtualized datacentres

More from The Register

next story
Boffins who stare at goats: I do believe they’re SHRINKING
Alpine chamois being squashed by global warming
What's that STINK? Rosetta probe shoves nose under comet's tail
Rotten eggs, horse dung and almonds – yuck
Comet Siding Spring revealed as flying molehill
Hiding from this space pimple isn't going to do humanity's reputation any good
Kip Thorne explains how he created the black hole for Interstellar
Movie special effects project spawns academic papers on gravitational lensing
Experts brand LOHAN's squeaky-clean box
Phytosanitary treatment renders Vulture 2 crate fit for export
LONG ARM of the SAUR: Brachially gifted dino bone conundrum solved
Deinocheirus mirificus was a bit of a knuckle dragger
Moment of truth for LOHAN's servos: Our US allies are poised for final test flight
Will Vulture 2 freeze at altitude? Edge Research Lab to find out
prev story

Whitepapers

Why cloud backup?
Combining the latest advancements in disk-based backup with secure, integrated, cloud technologies offer organizations fast and assured recovery of their critical enterprise data.
A strategic approach to identity relationship management
ForgeRock commissioned Forrester to evaluate companies’ IAM practices and requirements when it comes to customer-facing scenarios versus employee-facing ones.
Security for virtualized datacentres
Legacy security solutions are inefficient due to the architectural differences between physical and virtual environments.
Reg Reader Research: SaaS based Email and Office Productivity Tools
Read this Reg reader report which provides advice and guidance for SMBs towards the use of SaaS based email and Office productivity tools.
New hybrid storage solutions
Tackling data challenges through emerging hybrid storage solutions that enable optimum database performance whilst managing costs and increasingly large data stores.